Browse Guides  internal medicine  gastroenterology

Inflammatory bowel disease

Prevalence
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Investigations
  • ANCA and ASCA (anti-Saccharomyces cerevisiae antibodies) in new cases a c

Why?

A positive ANCA or ASCA diagnoses inflammatory bowel disease

Patient Target Disorder and
Reference Standard
Diagnostic Test LR+
(95% CI)
Post-test Probability LR-
(95% CI)
Post-test Probability
inflammatory bowel disease c   (pre-test probability: 50%) inflammatory bowel disease
(radiology, endoscopy and histology, negative culture)
p-ANCA infinity
(4.3 to infinity)
100% 0.61
(0.57 to 0.66)
39%
children with suspected inflammatory bowel disease a   (pre-test probability: 42%) inflammatory bowel disease
(colonoscopy and histology))
ASCA IgA > 20 or IgG > 40 EU/ml, or ANCA > mean 20 EU/ml 13
(4.8 to 33)
90% 0.33
(0.22 to 0.50)
20%

Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   L   Friedman
CAT Writers   D   Ford , CM   Ball